{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:11:41Z","timestamp":1786119101859,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1097\/mao.0b013e31815aea05","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T21:25:05Z","timestamp":1236201905000},"page":"1140-1144","source":"Crossref","is-referenced-by-count":30,"title":["Long-Term Vertigo Control in Patients After Intratympanic Gentamicin Instillation for M\u00e9ni;\u00e8re's Disease"],"prefix":"10.1097","volume":"28","author":[{"given":"Daniel","family":"Bodmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Morong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashlin","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian M.","family":"Nedzelski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-28-20210212","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2165\/00003495-200161080-00005","article-title":"Meniere's disease. Pathophysiology and treatment.","volume":"61","author":"Thai-Van","year":"2001","journal-title":"Drugs"},{"key":"R2-28-20210212","first-page":"1","article-title":"Ablation therapy in the management of Meniere's disease.","volume":"132","author":"Schuknecht","year":"1957","journal-title":"Acta Otolaryngol"},{"key":"R3-28-20210212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/00034894800896S302","article-title":"Aminoglycosides ototoxicity following middle ear injection.","volume":"89","author":"Rudnick","year":"1980","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"R4-28-20210212","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0196-0709(82)80042-2","article-title":"Vestibular ototoxicity in the chick: effects of streptomycin on equilibrium and on ampullary dark cells.","volume":"6","author":"Park","year":"1982","journal-title":"Am J Otolaryngol"},{"key":"R5-28-20210212","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0196-0709(85)80013-2","article-title":"Gentamicin tympanoclisis: effects on the vestibular secretory cells.","volume":"6","author":"Pender","year":"1985","journal-title":"Am J Otolaryngol"},{"key":"R6-28-20210212","first-page":"149","article-title":"Ten years experience with intratympanically applied streptomycin in the therapy of Morbus Meniere.","volume":"221","author":"Beck","year":"1978","journal-title":"Arch Otolaryngol"},{"key":"R7-28-20210212","first-page":"94","article-title":"Treatment of Meniere's disease with topical gentamicin: a preliminary report.","volume":"21","author":"Nedzelski","year":"1992","journal-title":"J Otolaryngol"},{"key":"R8-28-20210212","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1055\/s-2007-1008932","article-title":"Treatment of Morbus Meniere with intratympanically applied gentamicin.","volume":"59","author":"Schmidt","year":"1980","journal-title":"Laryngorhinootologie"},{"key":"R9-28-20210212","first-page":"44","article-title":"Intratympanic gentamicin for Meniere's disease.","volume":"18","author":"Hirsch","year":"1999","journal-title":"Am J Otol"},{"key":"R10-28-20210212","first-page":"18","article-title":"Chemical labyrinthectomy: local application of gentamicin for the treatment of unilateral Meniere's disease.","volume":"13","author":"Nedzelski","year":"1992","journal-title":"Am J Otol"},{"key":"R11-28-20210212","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1177\/019459988509300501","article-title":"Committee on Hearing and Equilibrium guidelines for reporting treatment results in Meniere's disease.","volume":"93","author":"Pearson","year":"1985","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R12-28-20210212","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1001\/archotol.1990.01870040046011","article-title":"The development of the Dizziness Handicap Inventory.","volume":"116","author":"Jacobson","year":"1990","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R13-28-20210212","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/00005537-200305000-00009","article-title":"Long-term hearing outcome in patients receiving intratympanic gentamicin for Meniere's disease.","volume":"113","author":"Wu","year":"2003","journal-title":"Laryngoscope"},{"key":"R14-28-20210212","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1177\/014556130608500811","article-title":"Long-term follow-up after gentamicin application via the Silverstein MicroWick in the treatment of Meniere's disease.","volume":"85","author":"Hill","year":"2006","journal-title":"Ear Nose Throat J"},{"key":"R16-28-20210212","first-page":"383","article-title":"Vestibular and audiologic functions in gentamicin treated Meniere's disease.","volume":"9","author":"Moller","year":"1988","journal-title":"Am J Otol"},{"key":"R17-28-20210212","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2310\/7070.2003.11249","article-title":"Intratympanic gentamicin for intractable Meniere's disease: 5-year follow-up.","volume":"32","author":"Atlas","year":"2003","journal-title":"J Otolaryngol"},{"key":"R18-28-20210212","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2310\/7070.2003.13863","article-title":"Systematic review of intratympanic gentamicin in Meniere's disease.","volume":"32","author":"Diamond","year":"2003","journal-title":"J Otolaryngol"},{"key":"R19-28-20210212","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2273.1999.00203.x","article-title":"The effect of severity of unilateral vestibular dysfunction on symptoms, disabilities, and handicap in vertigious patients.","volume":"24","author":"Bamiou","year":"1999","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"R20-28-20210212","first-page":"145","article-title":"Factor analysis and correlation between Dizziness Handicap Inventory and dizziness characteristics and impact on quality of life scales.","volume":"545","author":"Perez","year":"2001","journal-title":"Acta Otolaryngol Suppl"},{"key":"R21-28-20210212","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000013781","article-title":"Long-term outcome of Meniere's disease: endolymphatic mastoid shunt versus natural history.","volume":"3","author":"Quaranta","year":"1998","journal-title":"Audiol Neurotol"},{"key":"R22-28-20210212","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00020840-199610000-00006","article-title":"Topical drugs in the treatment of Meniere's disease.","volume":"4","author":"Commins","year":"1996","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"R23-28-20210212","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3233\/VES-2005-15304","article-title":"VEMPs and dynamic posturography after intratympanic gentamicin in Meniere's disease.","volume":"15","author":"Picciotti","year":"2005","journal-title":"J Vestib Res"},{"key":"R24-28-20210212","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1177\/000348940511401007","article-title":"Angular vestibulo-ocular reflex gains correlate with vertigo control after intratympanic gentamicin treatment for Meniere's disease.","volume":"114","author":"Lin","year":"2005","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"R25-28-20210212","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2310\/7070.2002.19065","article-title":"Hearing loss following intratympanic instillation of gentamicin for the treatment of unilateral Meniere's disease.","volume":"31","author":"Kaplan","year":"2002","journal-title":"J Otolaryngol"},{"key":"R26-28-20210212","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1097\/00005537-200008000-00014","article-title":"Intratympanic gentamicin for the treatment of unilateral Meniere's disease.","volume":"110","author":"Kaplan","year":"2000","journal-title":"Laryngoscope"},{"key":"R27-28-20210212","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/00016480600672600","article-title":"Histopathology of the vestibular organ after intratympanic gentamicin failure for Meniere's disease.","volume":"127","author":"Ishiyama","year":"2007","journal-title":"Acta Otolaryngol"},{"key":"R28-28-20210212","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0385-8146(04)00147-6","article-title":"Effects of aminoglycoside administration on cochlear elements in human temporal bones.","volume":"31","author":"Kusunoki","year":"2004","journal-title":"Auris Nasus Larynx"}],"container-title":["Otology & Neurotology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MAO.0b013e31815aea05","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:46:49Z","timestamp":1786038409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00129492-200712000-00028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/mao.0b013e31815aea05","relation":{},"ISSN":["1531-7129"],"issn-type":[{"value":"1531-7129","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}